Efficacy and Safety of Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)/ Eosinophilic Chronic Rhinosinusitis (ECRS)

NCT04607005 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

169

Enrollment

INDUSTRY

Sponsor class

Conditions

Nasal Polyps

Interventions

DRUG: Mepolizumab
DRUG: Placebo
DRUG: Standard of care

Sponsor

GlaxoSmithKline

Collaborators

[object Object]
[object Object]